Madison based Venture Investors has completed fundraising for their fifth fund, which will target 12-15 early stage life science and technology companies over the next 3-5 years. The VC’s latest fund totals $80 million and will primarily target companies in the Midwest. Venture Investors was established in 1982 with its first four funds totaling $177.6M. They have invested in 68 companies to date, including Promega, Third Wave Technologies, and TomoTherapy. Read more about their latest fund here.